Latest Regulatory News

Cosmos Exploration has finalised its acquisition of EAU Lithium, issuing 108 million shares to former EAU shareholders and appointing James Durrant as Chairman to drive its Bolivian lithium ambitions.

Metro Performance Glass has significantly improved its financial footing in FY26, cutting net debt by more than half and boosting EBITDA before significant items to $18.2 million despite subdued markets in New Zealand and Australia.

Cauldron Energy has outlined a substantial new uranium exploration target on recently acquired tenements adjacent to Paladin’s Manyingee deposit, underpinning Yanrey’s growing status as a major uranium province in Western Australia.

International Graphite Limited and Italian chemical producer Alkeemia have formalised a joint venture to develop a major graphite processing facility in Porto Marghera, Italy, targeting 15,000 tonnes per year by 2029 with first production expected in 2027.

Recce Pharmaceuticals has signed a non-binding term sheet with a major Middle Eastern pharma player for exclusive rights to commercialise its R327 Topical Gel across the MENA region, targeting a high diabetes burden market.

Bass Oil has landed a $3.5 million grant from the South Australian Government to fund a production pipeline for its 100% owned Kiwi gas project, aiming to connect it to Cooper Basin infrastructure and boost domestic gas supply by 2028.

Maronan Metals has completed a $22 million strategic placement with Kinterra Capital, which now holds nearly 20% of the company. The funds will accelerate an expanded 2026 drilling campaign and Preliminary Feasibility Study for the Maronan Project in Queensland.

Neurizon Therapeutics has boosted the participant count in its HEALEY ALS Platform Trial Regimen I from 160 to 240, capitalising on faster enrolment and philanthropic support to maintain costs and accelerate topline results to early Q3 2027.

Harvest Technology Group secures a A$6.5 million two-tranche placement to fund its defence strategy, expand Nodestream, and strengthen its balance sheet ahead of key growth initiatives.

Cryosite Limited delivered a robust 22% revenue increase and 28% EBITDA growth for the ten months to April 2026, powered by expanding clinical trial activity and infrastructure upgrades.

Memphasys has landed a major 1,000-cartridge order for its Felix™ System from MENA distributor ITL, with strong repeat demand from Qatar’s Hamad Medical Corporation and new market expansions into UAE, Kuwait, and soon Turkey.

Redcastle Resources has launched continuous mining at its Redcastle Reef gold deposit, advancing from exploration to production under a capital-light joint venture with BML Ventures. Ore haulage to third-party processing is scheduled to begin in June 2026, with first toll treatment expected in July.